• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《COVID-19 患者静脉血栓栓塞现象综述》

A Review of Venous Thromboembolism Phenomena in COVID-19 Patients.

机构信息

Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Curr Probl Cardiol. 2021 Mar;46(3):100692. doi: 10.1016/j.cpcardiol.2020.100692. Epub 2020 Aug 28.

DOI:10.1016/j.cpcardiol.2020.100692
PMID:32994052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7452823/
Abstract

With the outbreak of the second peak of COVID-19 in many countries of the world, the symptoms and complications of this disease has received a great deal of attention. One of the most important known complications of severe acute respiratory syndrome coronavirus 2 is the occurrence of venous thromboembolic events, especially in critically ill patients who are hospitalized in the intensive care unit. The pathology of this event is complex and multifactorial, but the main problem now is the timely diagnosis of these phenomena, which can reduce the mortality and morbidity of patients. Deterioration of clinical condition in patients with severe acute respiratory syndrome coronavirus 2 infection along with increased coagulation markers can increase clinical suspicion of venous thromboembolic events. Imaging techniques, especially computed tomography pulmonary angiography, can well solve this puzzle and lead to timely treatment of these patients.

摘要

随着世界上许多国家 COVID-19 第二波高峰的爆发,这种疾病的症状和并发症受到了极大的关注。严重急性呼吸综合征冠状病毒 2 最重要的已知并发症之一是静脉血栓栓塞事件的发生,特别是在重症监护病房住院的危重病患者中。这种事件的病理学是复杂的和多因素的,但目前的主要问题是及时诊断这些现象,这可以降低患者的死亡率和发病率。严重急性呼吸综合征冠状病毒 2 感染患者的临床状况恶化以及凝血标志物增加会增加对静脉血栓栓塞事件的临床怀疑。成像技术,特别是计算机断层扫描肺动脉造影,可以很好地解决这个难题,并导致及时治疗这些患者。

相似文献

1
A Review of Venous Thromboembolism Phenomena in COVID-19 Patients.《COVID-19 患者静脉血栓栓塞现象综述》
Curr Probl Cardiol. 2021 Mar;46(3):100692. doi: 10.1016/j.cpcardiol.2020.100692. Epub 2020 Aug 28.
2
A review of venous thromboembolism in COVID-19: A clinical perspective.COVID-19 相关静脉血栓栓塞症的研究进展:临床视角
Clin Respir J. 2021 May;15(5):506-512. doi: 10.1111/crj.13330. Epub 2021 Feb 5.
3
Trends (2020-2022) toward Reduced Prevalence of Postcoronavirus Disease Syndrome and Improved Quality of Life for Hospitalized Coronavirus Disease 2019 Patients with Severe Infection and Venous Thromboembolism.2020-2022 年,严重感染和静脉血栓栓塞的 2019 年冠状病毒病住院患者中,冠状病毒病后综合征的发病率降低,生活质量提高的趋势。
Semin Thromb Hemost. 2024 Sep;50(6):835-841. doi: 10.1055/s-0043-1776004. Epub 2023 Oct 13.
4
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.严重 COVID-19 高凝状态下常规静脉血栓栓塞预防可能不足。
Crit Care Med. 2020 Sep;48(9):e783-e790. doi: 10.1097/CCM.0000000000004466.
5
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
6
Pulmonary Thrombosis and Thromboembolism in COVID-19.新型冠状病毒肺炎相关肺血栓栓塞症
Chest. 2021 Oct;160(4):1471-1480. doi: 10.1016/j.chest.2021.06.016. Epub 2021 Jun 19.
7
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.COVID-19中的静脉血栓栓塞性疾病:病理生理学、治疗与预防
Int J Mol Sci. 2022 Sep 8;23(18):10372. doi: 10.3390/ijms231810372.
8
Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy.意大利西北部 COVID-19 相关急性呼吸窘迫综合征危重症患者的静脉血栓栓塞症。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9154-9160. doi: 10.26355/eurrev_202009_22864.
9
Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study.重症监护病房与非重症监护病房的新型冠状病毒 2 型(SARS-CoV-2)感染重症患者的血栓栓塞发生率相似:一项回顾性队列研究
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211053315. doi: 10.1177/10760296211053315.
10
Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.基于 CT 扫描的静脉-静脉体外膜肺氧合治疗严重急性呼吸综合征冠状病毒 2 后静脉血栓栓塞事件。
Crit Care Med. 2020 Oct;48(10):e971-e975. doi: 10.1097/CCM.0000000000004504.

引用本文的文献

1
Sex differences in cardiovascular complications and mortality in hospital patients with covid-19: registry based observational study.新冠肺炎住院患者心血管并发症及死亡率的性别差异:基于登记处的观察性研究
BMJ Med. 2023 Feb 14;2(1):e000245. doi: 10.1136/bmjmed-2022-000245. eCollection 2023.
2
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement.高级影像学支持自身免疫和斑块破裂在 COVID-19 心脏受累中的发病机制作用。
Clin Rev Allergy Immunol. 2023 Feb;64(1):75-89. doi: 10.1007/s12016-022-08925-1. Epub 2022 Jan 28.
3
Cardiovascular Disease Complicating COVID-19 in the Elderly.老年 COVID-19 合并心血管疾病。
Medicina (Kaunas). 2021 Aug 17;57(8):833. doi: 10.3390/medicina57080833.
4
The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan.日本住院 COVID-19 患者入院前抗血小板和抗凝治疗对疾病严重程度的影响。
J Infect Chemother. 2021 Oct;27(10):1498-1503. doi: 10.1016/j.jiac.2021.07.016. Epub 2021 Jul 24.
5
Anticoagulation in the obese patient with COVID-19-associated venous thromboembolism.肥胖 COVID-19 相关静脉血栓栓塞患者的抗凝治疗。
BMJ Case Rep. 2021 Jun 11;14(6):e242675. doi: 10.1136/bcr-2021-242675.
6
Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis.新型冠状病毒肺炎患者肺栓塞及 D-二聚体评估价值的 Meta 分析。
Eur Radiol. 2021 Nov;31(11):8168-8186. doi: 10.1007/s00330-021-08003-8. Epub 2021 May 9.
7
A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction.冠状动脉血栓形成综述:COVID-19 患者和 ST 段抬高型心肌梗死中的新挑战发现。
Curr Probl Cardiol. 2021 Mar;46(3):100744. doi: 10.1016/j.cpcardiol.2020.100744. Epub 2020 Nov 2.

本文引用的文献

1
Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.新冠病毒感染患者的凝血病与抗凝治疗的可能获益。
Curr Probl Cardiol. 2020 Sep;45(9):100648. doi: 10.1016/j.cpcardiol.2020.100648. Epub 2020 Jun 27.
2
Pulmonary embolism in COVID-19 patients: a French multicentre cohort study.新型冠状病毒肺炎患者的肺栓塞:一项法国多中心队列研究。
Eur Heart J. 2020 Jul 1;41(32):3058-3068. doi: 10.1093/eurheartj/ehaa500.
3
Pulmonary embolism: A complication of COVID 19 infection.肺栓塞:COVID-19 感染的并发症。
Thromb Res. 2020 Sep;193:79-82. doi: 10.1016/j.thromres.2020.05.033. Epub 2020 May 25.
4
COVID-19 quarantine and acute pulmonary embolism.新型冠状病毒肺炎隔离与急性肺栓塞
Rev Esp Cardiol (Engl Ed). 2020 Aug;73(8):680-682. doi: 10.1016/j.rec.2020.05.010. Epub 2020 May 23.
5
Thrombosis risk associated with COVID-19 infection. A scoping review.与 COVID-19 感染相关的血栓形成风险。范围综述。
Thromb Res. 2020 Aug;192:152-160. doi: 10.1016/j.thromres.2020.05.039. Epub 2020 May 27.
6
Acute pulmonary embolism in COVID-19 related hypercoagulability.COVID-19 相关高凝状态下的急性肺栓塞。
J Thromb Thrombolysis. 2020 Jul;50(1):223-226. doi: 10.1007/s11239-020-02160-1.
7
Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.新型冠状病毒肺炎(COVID-19)与肺栓塞并存:双重病理诊断面临的挑战
Thorax. 2020 Sep;75(9):812-814. doi: 10.1136/thoraxjnl-2020-215011. Epub 2020 May 23.
8
Pulmonary Thromboembolism as a Potential Cause of Clinical Deterioration in COVID-19 Patients; a Commentary.肺血栓栓塞症作为COVID-19患者临床病情恶化的潜在原因;一篇评论
Arch Acad Emerg Med. 2020 Apr 19;8(1):e52. eCollection 2020.
9
Incidence of pulmonary embolism in patients with COVID-19.新型冠状病毒肺炎患者肺栓塞的发病率
Intensive Care Med. 2020 Jul;46(7):1500-1501. doi: 10.1007/s00134-020-06081-8. Epub 2020 May 20.
10
Acute Pulmonary Embolism and COVID-19.急性肺栓塞与 COVID-19。
Radiology. 2020 Dec;297(3):E335-E338. doi: 10.1148/radiol.2020201955. Epub 2020 May 14.